Security key
28658R106
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 4,228,394
- Total 13F value
- $55,138,258
- Share change
- +2,757,291
- SEC-reported price per share
- $13.04
- Number of holders
- 22
- Value change
- +$37,208,103
- Number of buys
- 19
- Number of sells
- 5
- Shares outstanding
- 57,061,882
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2026
Institutions
22
Top holders
10
CLYM full security history
Ownership snapshot
Full 13F holder table
Previous quarter: Q4 2025
Climb Bio, Inc. SEC filings
Climb Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 28658R106
Recent filing periods:
Ownership snapshot
Top reported holders of CLYM - Climb Bio, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
RA CAPITAL MANAGEMENT, L.P.
Comparable rows
15/15
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 12%
13D/G row: FMR LLC
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 12%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
12%
Pontifax Management 4 G.P. (2015)...
7.7%
MPM BioImpact LLC
5.6%
RA CAPITAL MANAGEMENT, L.P.
20%
PRICE T ROWE ASSOCIATES INC /MD/
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
12%
|
$75,644,655
6,790,364 shares
|
$0 | 30 Jun 2026 |
| Pontifax Management 4 G.P. (2015) Ltd. |
13D/G
Pontifax VI G.P. L.P.
|
7.7%
|
$12,911,822
5,206,380 shares
|
$0 | 27 Jun 2024 |
| MPM BioImpact LLC |
13F
13D/G
Company
|
5.6%
from 13D/G
|
$17,765,057
2,593,439 shares
|
— | 31 Mar 2026 |
| RA CAPITAL MANAGEMENT, L.P. |
13F
3/4/5
Company · Director, 10%+ Owner
|
20%
|
$77,411,432
11,300,939 shares
|
— | 31 Mar 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
Company
|
3.4%
|
$13,132,000
1,916,968 shares
|
— | 31 Mar 2026 |
| BRAIDWELL LP |
13F
Company
|
2.7%
|
$10,478,274
1,529,675 shares
|
— | 31 Mar 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
4,228,394
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2026 vs Q4 2025 Across Filers
Q4 2025 holders
64
Q2 2026 holders
22
Holder diff
-42
| Investor | Q4 2025 Shares | Q2 2026 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend